🔗 Permalink

Assignee profile:

SAREPTA THERAPEUTICS, INC.

City:

BOTHELL, Washington

Country:

United States

Published Applications:

Last publication date:

2015-06-04

Patent Grants:

Last grant date:

2018-04-17

Top Inventors for applications by SAREPTA THERAPEUTICS, INC.

These are the the leading inventors for applications assigned to SAREPTA THERAPEUTICS, INC.:

Peter SAZANI 4 Bothell, WA United States
Ryszard KOLE 4 Bellevue, WA United States
Diane Elizabeth FRANK 3 Seattle, WA United States
Richard K. BESTWICK 3 Corvallis, OR United States

Patrick L. Iversen 2 Corvallis, OR United States
Peter Linsley 2 Seattle, WA United States
Brian James Leppert 2 Kenmore, WA United States
Edward M. Kaye 2 Cambridge, MA United States

Ryszard Kole 2 Corvallis, OR United States
SAREPTA THERAPEUTICS, INC. 2 , United States
The United States of America, as represented by 1 , United States
Fred Joseph Schnell 1 Cambridge, MA United States

UNIVERSITY OF MARYLAND 1 , United States
Francis S. Collins 1 Chevy Chase, MD United States
Robert Hudziak 1 Blodgett, OR United States
Richard Keith Bestwick 1 Corvallis, OR United States

Gunnar J. Hanson 1 Bothell, WA United States
Michael R. Erdos 1 Severna Park, MD United States
SAREPTA THERAPEUTICS, INC. 1 BOTHELL, WA United States
Kan Cao 1 Bowie, MD United States

Recent patent applications by SAREPTA THERAPEUTICS, INC.

SAREPTA THERAPEUTICS, INC. based in BOTHELL, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-06-04

US20150152415A1

Chemistry; metallurgy

MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD

#2 | 2014-11-06

US20140329881A1

Chemistry; metallurgy

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#3 | 2014-11-06 ✅ Patent 9,944,926 granted on 2018-04-17

US20140329772A1

Chemistry; metallurgy

Induced exon inclusion in spinal muscle atrophy

#4 | 2014-11-06

US20140329762A1

Chemistry; metallurgy

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#5 | 2014-10-30 ✅ Patent 9,217,148 granted on 2015-12-22

US20140323544A1

Chemistry; metallurgy

Exon skipping compositions for treating muscular dystrophy

#6 | 2014-10-23

US20140315977A1

Chemistry; metallurgy

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#7 | 2014-10-23 ✅ Patent 9,506,058 granted on 2016-11-29

US20140315862A1

Chemistry; metallurgy

Compositions for treating muscular dystrophy

#8 | 2014-10-09 ✅ Patent 10,066,228 granted on 2018-09-04

US20140303238A1

Chemistry; metallurgy

Oligonucleotides for treating expanded repeat diseases

#9 | 2014-04-03

US20140094500A1

Chemistry; metallurgy

MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD

#10 | 2014-02-13 ✅ Patent 8,895,722 granted on 2014-11-25

US20140045916A1

Chemistry; metallurgy

Splice-region antisense composition and method

#11 | 2014-01-23 ✅ Patent 9,066,967 granted on 2015-06-30

US20140024821A1

Chemistry; metallurgy

Oligonucleotide analogues targeting human LMNA

#12 | 2014-01-23 ✅ Patent 9,326,992 granted on 2016-05-03

US20140024698A1

Human necessities

Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

#13 | 2013-10-31 ✅ Patent 10,017,763 granted on 2018-07-10

US20130288369A1

Chemistry; metallurgy

dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups

#14 | 2013-07-25 ✅ Patent 8,865,883 granted on 2014-10-21

US20130190390A1

Chemistry; metallurgy

Multiple exon skipping compositions for DMD

#15 | 2010-05-27 ✅ Patent 8,871,918 granted on 2014-10-28

US20100130591A1

Chemistry; metallurgy

Multiple exon skipping compositions for DMD

Also check out Sarepta Therapeutics, Inc.'s (Bothell, United States) applicant profile with 7 patent applications submitted.

AssigneeID:

31825 ⎘